ATE209910T1 - Verwendung von 6,7-substituierter 2- aminotetraline zur behandlung von zytokin- vermittleten entzündungszuständen - Google Patents
Verwendung von 6,7-substituierter 2- aminotetraline zur behandlung von zytokin- vermittleten entzündungszuständenInfo
- Publication number
- ATE209910T1 ATE209910T1 AT98946704T AT98946704T ATE209910T1 AT E209910 T1 ATE209910 T1 AT E209910T1 AT 98946704 T AT98946704 T AT 98946704T AT 98946704 T AT98946704 T AT 98946704T AT E209910 T1 ATE209910 T1 AT E209910T1
- Authority
- AT
- Austria
- Prior art keywords
- substituted
- aminotetraline
- cytokine
- treatment
- inflammatory conditions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT97RM000569A IT1294932B1 (it) | 1997-09-22 | 1997-09-22 | Uso di 2-amminotetraline-6,7 sostituite per la preparazione di composizioni farmaceutiche atte al trattamento di patologie |
| PCT/IT1998/000250 WO1999015160A2 (en) | 1997-09-22 | 1998-09-18 | Use of 6,7-substituted 2-aminotetralines suitable for preparing pharmaceutical composition for the therapeutic treatment of inflammatory and/or autoimmune pathologies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE209910T1 true ATE209910T1 (de) | 2001-12-15 |
Family
ID=11405258
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98946704T ATE209910T1 (de) | 1997-09-22 | 1998-09-18 | Verwendung von 6,7-substituierter 2- aminotetraline zur behandlung von zytokin- vermittleten entzündungszuständen |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6242497B1 (de) |
| EP (1) | EP1017377B1 (de) |
| JP (1) | JP2001517618A (de) |
| KR (1) | KR20010030670A (de) |
| CN (1) | CN1276721A (de) |
| AT (1) | ATE209910T1 (de) |
| AU (1) | AU735369B2 (de) |
| BR (1) | BR9812489A (de) |
| CA (1) | CA2303918A1 (de) |
| DE (1) | DE69802828T2 (de) |
| DK (1) | DK1017377T3 (de) |
| ES (1) | ES2167942T3 (de) |
| IT (1) | IT1294932B1 (de) |
| MX (1) | MXPA00002774A (de) |
| NZ (1) | NZ503391A (de) |
| PT (1) | PT1017377E (de) |
| WO (1) | WO1999015160A2 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1294931B1 (it) * | 1997-09-22 | 1999-04-23 | Sigma Tau Ind Farmaceuti | Derivati della 2-amminotetralina procedimento per la loro preparazione e composizioni farmaceutiche che li contengono, attive nella |
| WO2011047350A2 (en) * | 2009-10-16 | 2011-04-21 | David Helton | Emesis treatment |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1241988B (it) * | 1990-06-15 | 1994-02-02 | Sigma Tau Ind Farmaceuti | 2- amminotetraline-6, 7-sostituite attive come immunomodulanti e composizioni farmaceutiche che le contengono |
| IT1278045B1 (it) * | 1995-03-09 | 1997-11-17 | Sigma Tau Ind Farmaceuti | Uso di 2-amminotetraline-6,7-sostituite per la preparazione di composizioni farmaceutiche atte al trattamento dello shock, e di |
-
1997
- 1997-09-22 IT IT97RM000569A patent/IT1294932B1/it active IP Right Grant
-
1998
- 1998-09-18 DK DK98946704T patent/DK1017377T3/da active
- 1998-09-18 CA CA002303918A patent/CA2303918A1/en not_active Abandoned
- 1998-09-18 NZ NZ503391A patent/NZ503391A/en unknown
- 1998-09-18 ES ES98946704T patent/ES2167942T3/es not_active Expired - Lifetime
- 1998-09-18 BR BR9812489-7A patent/BR9812489A/pt not_active IP Right Cessation
- 1998-09-18 AU AU93661/98A patent/AU735369B2/en not_active Ceased
- 1998-09-18 MX MXPA00002774A patent/MXPA00002774A/es unknown
- 1998-09-18 WO PCT/IT1998/000250 patent/WO1999015160A2/en not_active Application Discontinuation
- 1998-09-18 DE DE69802828T patent/DE69802828T2/de not_active Expired - Fee Related
- 1998-09-18 JP JP2000512530A patent/JP2001517618A/ja active Pending
- 1998-09-18 EP EP98946704A patent/EP1017377B1/de not_active Expired - Lifetime
- 1998-09-18 CN CN98810460A patent/CN1276721A/zh active Pending
- 1998-09-18 KR KR1020007003076A patent/KR20010030670A/ko not_active Application Discontinuation
- 1998-09-18 PT PT98946704T patent/PT1017377E/pt unknown
- 1998-09-18 AT AT98946704T patent/ATE209910T1/de not_active IP Right Cessation
-
2000
- 2000-03-22 US US09/533,066 patent/US6242497B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US6242497B1 (en) | 2001-06-05 |
| EP1017377B1 (de) | 2001-12-05 |
| CN1276721A (zh) | 2000-12-13 |
| ITRM970569A1 (it) | 1999-03-22 |
| JP2001517618A (ja) | 2001-10-09 |
| AU735369B2 (en) | 2001-07-05 |
| EP1017377A2 (de) | 2000-07-12 |
| NZ503391A (en) | 2001-06-29 |
| DK1017377T3 (da) | 2002-03-04 |
| AU9366198A (en) | 1999-04-12 |
| PT1017377E (pt) | 2002-04-29 |
| IT1294932B1 (it) | 1999-04-23 |
| KR20010030670A (ko) | 2001-04-16 |
| WO1999015160A2 (en) | 1999-04-01 |
| BR9812489A (pt) | 2000-09-26 |
| WO1999015160A3 (en) | 1999-05-20 |
| DE69802828T2 (de) | 2002-07-18 |
| ES2167942T3 (es) | 2002-05-16 |
| CA2303918A1 (en) | 1999-04-01 |
| MXPA00002774A (es) | 2002-10-31 |
| DE69802828D1 (de) | 2002-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE225176T1 (de) | Verwendung von serotonin-antagonisten (5ht3) zur behandlung von fibromyalgie | |
| DE69724016D1 (de) | Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen erkrankungen der atemwege | |
| ATE255896T1 (de) | Tetrahydropteridine und pyridylpiperazine zur behandlung von neurologischen störungen | |
| FI935585A0 (fi) | Pyrrolopyrimidiner | |
| DE122009000012I1 (de) | Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen. | |
| DE59611411D1 (de) | Verwendung von alpha 1l-agonisten zur behandlung der harninkontinenz | |
| DE3683318D1 (de) | Verwendung von alfuzosin zur behandlung von erkrankungen der harnwege. | |
| DE3579113D1 (de) | Zusammensetzungen zur milderung, behandlung und bestimmungung von arthritschen krankheiten und aehnlichen zustaenden. | |
| EA199800667A1 (ru) | Новые фенантридины | |
| ATE313326T1 (de) | VERWENDUNG VON CABERGOLIN ZUR BEHANDLUNG VON ßRESTLESS LEGS SYNDROMß | |
| DE69111596D1 (de) | Verwendung von zwitterionen zur mobilisierung isoelektrisch fokussierter ampholytzonen. | |
| ATE198895T1 (de) | Verwendung von bindungsreagenzien gegen cd23 in der behandlung von autoimmunkrankheiten | |
| DE69738045D1 (de) | Verwendung von cetrorelix zur behandlung von benigne prostatahypertrophie und prostatakrebs | |
| ATE210447T1 (de) | Verwendung von cck-b rezeptor antagonisten zur behandlung von schlafstörungen | |
| ATE209891T1 (de) | Verwendung von 1-hydroxy-2-pyridonen zur behandlung der seborrhoischen dermatitis | |
| DE68911776D1 (de) | Konjugierte Oxybutenolide zur Behandlung von Ulcera. | |
| DE69729735D1 (de) | Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen | |
| DE69626816D1 (de) | Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren | |
| DE69701458D1 (de) | Verwendung von buckminsterfulleren zur behandlung neurotoxischer verletzungen | |
| ATE209910T1 (de) | Verwendung von 6,7-substituierter 2- aminotetraline zur behandlung von zytokin- vermittleten entzündungszuständen | |
| DE69936779D1 (de) | Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen | |
| DE3785555D1 (de) | Verwendung von guaifenesin zur behandlung urologischer beschwerden. | |
| ATE303158T1 (de) | Verwendung von beta-interferon zur behandlung der restenose | |
| ATE225181T1 (de) | Verwendung von heparinen niedrigeren molekulargewichtes zur behandlung von hirnödemen | |
| DE69833557D1 (de) | Verwendung von spezifischen 'steady-state' calcium-r-kanalblockern |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |